本文選題：肝癌介入 + 化療�。� 參考：《中華醫(yī)院感染學(xué)雜志》2017年14期

【摘要】：目的回顧性分析肝癌介入化療患者醫(yī)院感染風(fēng)險(xiǎn)因素并研究防控對策。方法選取2013年1月-2016年1月942例肝癌介入化療患者,回顧性調(diào)查一般資料、介入手術(shù)情況、醫(yī)院感染、抗菌藥物使用時(shí)間、住院時(shí)間等,引入多因素Logistic回歸模型分析肝癌介入化療者醫(yī)院感染風(fēng)險(xiǎn)因素,總結(jié)防控對策。結(jié)果 942例患者,發(fā)生醫(yī)院感染50例,感染率為5.30%;多因素Logistic回歸模型分析,年齡60歲、糖尿病、白細(xì)胞計(jì)數(shù)2.5×109/L、白蛋白水平≤30g/L、皮膚或黏膜潰損、侵入性操作、介入手術(shù)時(shí)間180min、抗菌藥物使用時(shí)間≥7天、術(shù)中出血量≥500ml、傷口疼痛明顯和住院時(shí)間≥21天是肝癌介入化療者醫(yī)院感染的獨(dú)立風(fēng)險(xiǎn)因素,差異有統(tǒng)計(jì)學(xué)意義(P0.05)。結(jié)論不斷加強(qiáng)肝癌介入化療者醫(yī)院感染風(fēng)險(xiǎn)因素回顧性調(diào)查,明確風(fēng)險(xiǎn),早期改進(jìn)防控對策能最大程度控制醫(yī)院感染,提升醫(yī)院感染管理質(zhì)量。
[Abstract]:Objective to analyze the risk factors of hospital infection in patients with liver cancer Interventional Chemotherapy and to study the prevention and control measures. Methods 942 cases of interventional chemotherapy for liver cancer were selected in January 2013 -2016 years in January. The general data, the operation situation, the hospital infection, the time of the use of antibiotics and the residence time were reviewed, and the multiple factor Logistic regression model was introduced. The risk factors of nosocomial infection in the interventional chemotherapy of liver cancer were summarized. Results 50 cases of nosocomial infection occurred in 942 cases, the infection rate was 5.30%, the multiple factor Logistic regression model analysis, age 60 years old, diabetes, white blood cell count 2.5 x 109/L, albumin level less than 30g/L, skin skin or mucosa ulceration, invasive operation, interventional operation time 180min, The time of use of antibiotics is more than 7 days, the amount of bleeding in the operation is more than 500ml, the pain of the wound is obvious and the time of hospitalization is more than 21 days. It is the independent risk factor of the hospital infection of the interventional chemotherapy for the liver cancer. The difference is statistically significant (P0.05). Conclusion the retrospective investigation of the risk factors of the hospital infection in the interventional chemotherapy for liver cancer is continued, and the risk is clearly defined and the prevention and control of the prevention and control are improved. The strategy can control nosocomial infection and improve the quality of nosocomial infection management.
【作者單位】： 河南省南陽市中心醫(yī)院心臟大血管外科;河南省南陽市中心醫(yī)院感染科;河南省南陽市中心醫(yī)院普外科;
【分類號】：R735.7

【相似文獻(xiàn)】

相關(guān)期刊論文 前10條

1 南克俊,隋晨光,魏永長,李春麗,李毅,楊謹(jǐn),陳玲,劉亞民;影響中晚期肝癌介入化療預(yù)后的因素[J];癌癥;2002年08期

2 齊惠麗，蘇小玲，，朱望東;274例肝癌介入化療方案評價(jià)[J];醫(yī)學(xué)信息;1995年07期

3 武偉,林明足,戴

本文編號：1979070